BioVie Advances the BIV201 Clinical Program and Prefilled Syringe

NEXT STORY
Emergent BioSolutions Signs Agreement to be U.S. Manufacturing Partner for AstraZeneca’s COVID-19 Vaccine Candidate
PREV STORY
Diffusion Pharmaceuticals Files Clinical Trial Application for European Phase 1a/1b Study of TSC in COVID-19 Patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

PharmaTher Provides Research Update on Microneedle Patch Delivery Technologies for Psychedelics

author_avatar
NASDAQ Market News

School Specialty and Mobilize Rescue Systems Collaborate to Improve Student Safety through The 21st Century Safe School Initiative

Partnership to empower teachers, students and staff with vital tools for responding to medical ...

author_avatar
NASDAQ Market News

ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19

author_avatar
NASDAQ Market News